Megazyme International Ireland, now a key part of NEOGEN Corporation, is a globally recognized leader in the development, manufacture, and supply of high-quality diagnostic test kits, enzymes, and reagents. Founded in 1988 by Dr. Barry McCleary, Megazyme has established a strong reputation for scientific excellence and innovation. It serves a diverse range of industries, including food, feed, dairy, wine, brewing, biofuels, and chemicals worldwide. Megazyme's solutions are crucial for quality control, research, and product development, ensuring safety and consistency in various applications. The acquisition by NEOGEN in late 2020 has further expanded Megazyme's global reach and capabilities within the food safety and diagnostics market, integrating its specialized expertise with NEOGEN's broader portfolio and distribution network.
Serves as the main center for research and development, manufacturing of specialized diagnostic kits and enzymes, rigorous quality control, and overall company administration.
The facility houses state-of-the-art laboratories and specialized manufacturing units designed for enzyme purification, biochemical analysis, and diagnostic kit assembly.
A science-driven and innovative environment that fosters collaboration, precision, and a deep commitment to quality. The team largely consists of highly skilled scientists, researchers, and technicians dedicated to advancing analytical solutions for various industries.
The Bray headquarters is pivotal to Megazyme's international reputation for producing high-quality, reliable analytical products and its ongoing contributions to scientific research in food and agricultural diagnostics. It remains a center of excellence within the NEOGEN group.
Megazyme's specialized products are utilized by research institutions, food and beverage manufacturers, agricultural companies, and analytical laboratories in over 100 countries. Since its acquisition by NEOGEN Corporation, Megazyme's global reach has been significantly amplified through NEOGEN's extensive worldwide sales, marketing, and distribution network. This integrated structure supports global functions including international sales, localized technical support, efficient product distribution, and responsive customer service for its unique portfolio of enzyme and diagnostic testing solutions.
Block B, IDA Bray Business Park, Southern Cross Route
Bray
Co. Wicklow
Ireland
Address: Supported by NEOGEN Corporation's various global offices and distributor networks worldwide.
To provide localized access to Megazyme's specialized enzyme and diagnostic kit portfolio by leveraging NEOGEN's established global infrastructure. This enhances market penetration, customer service, and technical support in various regions across North America, Europe, Asia-Pacific, and Latin America.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Megazyme' leadership includes:
Megazyme has been backed by several prominent investors over the years, including:
No major executive hires or exits specific to the Megazyme International Ireland leadership team have been publicly announced in the last 12 months. The leadership structure, headed by General Manager Cian O'Neill, has remained stable following its integration into NEOGEN Corporation, which was completed prior to this period.
Discover the tools Megazyme uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Megazyme International Ireland, as part of NEOGEN Corporation, primarily utilizes its historical email format. Common professional email structures often include first initial followed by last name, or first name.last name. For Megazyme, the [first_initial][last_name]@megazyme.com format is prevalent.
[first_initial][last_name]@megazyme.com
Format
bmccleary@megazyme.com
Example
80%
Success rate
Megazyme Website News • December 5, 2023
Megazyme announced the launch of K-LATECH, a new liquid α-Amylase product derived from Aspergillus oryzae. This enzyme is specifically designed for applications in the brewing industry to precisely control enzyme activity during the mashing process....more
NEOGEN Corporation News • December 31, 2020
NEOGEN Corporation officially announced its acquisition of Megazyme, Ltd., a prominent supplier of analytical solutions for the global food and beverage industries. This strategic acquisition significantly expanded NEOGEN's food safety operations and product portfolio....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Megazyme, are just a search away.